Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions
- Venous Thrombosis
- Deep Vein Thrombosis
Interventions
- DRUG: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor
Bayer
Collaborators